Brian correctly points out that there should be regular monitoring of infusion sites. However, once the operator observes colour change and swelling, damage has already occurred. In neonates particularly it is important to use devices that can measure small changes in pressure. The line pressure will vary depending on syringe size, flowrate and drug viscosity. It is therefore important to measure the line pressure for a few minutes post setup and then set a pressure window on top of that. Should a pressure increase occur, then it will be detected early before there is visible signs of tissue damage. Some syringe drivers allow this accuracy by using pressure monitoring sets. Some users choose to follow this procedure - some do not. If there is an incident and the technology was available and not used, would this be criticised? Is it not true that in the best interests of patient safety particularly in our most vulnerable patients (neonates) that pressure monitoring be carefully applied.
